NIPH Clinical Trials Search

Basic Information

Recruitment status	recruiting
Health condition(s) or Problem(s) studied
Date of first enrollment	24/12/2020
Target sample size	34
Countries of recruitment	Japan,North America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Ramucirumab Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Cyclophosphamide Therapeutic category code : 421 Alkylating agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Vinorelbine Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	safety efficacy pharmacokinetics pharmacodynamics other

Key inclusion & exclusion criteria

Age minimum	>= 12month old
Age maximum	<= 29age old
Gender	Both
Include criteria
Exclude criteria